MentionFox
Home › funding signals › Pulmotherapeutics Inc
Form D · on the record

Pulmotherapeutics Inc — $500K Form D filing, April 2025

Before you sell to, join or invest in Pulmotherapeutics Inc

MentionFox check on Pulmotherapeutics Inc: only 1 source on file so far (checked 4 November 2026). Run a full check before you rely on it. mentionfox.com/c/funding/pulmotherapeutics-inc-form-d-25000001

Check Pulmotherapeutics Inc before you sell to, join or invest Free, no sign-up: every record on file, each linked to its source.

What do you want to do about Pulmotherapeutics Inc?

Based on the record MentionFox holds for this company. No flag is not a clearance.

Pulmotherapeutics Inc filed a Form D with the Securities and Exchange Commission on 2025-04-14.

Pulmotherapeutics Inc filed a Form D notice of an exempt securities offering with the SEC on April 14, 2025. The filing reports $500K sold. Its industry group is Biotechnology. It names Nagarjun Konduru Venkata (Executive Officer, Director) (SEC Form D, April 14, 2025).

5 more Biotechnology raises in Texas within 90 days ↓

Is this your company?

Key facts

Run the free check on Pulmotherapeutics Inc →

Sell to companies like Pulmotherapeutics Inc? Enter your website and see 10 with a filed reason to buy from you this month. Free.

Opens in a new tab. No signup.

Pulmotherapeutics Inc

New Form D on file · 2025-04-14 · the record

$500K
raise on the record
D
filing
3
investors in
TEXAS
based
Open the record →

What the record says

FilingForm D
Filed2025-04-14
Industry groupBiotechnology
Entity typeCorporation
Incorporated inDELAWARE
Year formed2024
BasedTYLER, TEXAS
CIK2064557
Accession0001641172-25-003937

Pitching, partnering or investing alongside them? See who really runs and owns Pulmotherapeutics Inc.

Free to see. No signup.

Keep reading

More on the people and the money behind Pulmotherapeutics Inc, from the filings we hold.

More raises like this

Biotechnology raises by companies based in Texas, filed within 90 days of this one, largest first.

What do you want to do with Pulmotherapeutics Inc?

Get the full cited report on Pulmotherapeutics Inc

What the filing shows about Pulmotherapeutics Inc

  • The filing reports $250K of the proceeds going to the company's own executives, directors or promoters.
  • 3 investors had already put money in when it filed.

Only in the Full Report: Who Runs It, And How To Reach Them · Warning Bells · Who Pays Them, And Who They Are Up Against.

Example from a real report (our sample on Target): “In March 2026, Target announced a planned incremental $1 billion operating investment” Source: Target Corporation (press release)

A Full Report on Pulmotherapeutics Inc: verified, sourced, every claim cited, ready in a few minutes. See pricing.

See a sample report

Who the filing names, and in what role

The filing gives Pulmotherapeutics Inc's address as 714 Huntwick Ln, Tyler, TX 75703.

Keep digging

Who else raised the same week in biotechnology

What the filing says

  • Offered: an open-ended amount (the filing says Indefinite). Sold: $500,000. Left to sell: open-ended (Indefinite). (filing)
  • Investors: 3 had already invested. (filing)
  • Date of first sale: March 27, 2025. (filing)
  • Types of securities: Equity. (filing)
  • Item 16, payments to executive officers, directors or promoters: $250,000 of the proceeds is used or proposed to be used for such payments. The filing explains: “The Chief Executive Officer would receive an estimated salary of $250,000” (filing)
  • On sales commissions and finders' fees: the filing adds “2.5% performance-based bonus per $1,000,000 raised” (filing)

This is the company's own disclosure. A payment disclosed on a Form D is a disclosed use of proceeds, not a finding of wrongdoing.

Order the Full Report on Pulmotherapeutics Inc See pricing

Is Pulmotherapeutics Inc a real, registered company?

Pulmotherapeutics Inc is a registered filer with the SEC (CIK 2064557) and has filed since 2025-04-14. 1 filing is on record, the latest on 2025-04-14.

A filing shows the company exists and what it reports about itself. It is not an audit or a rating.

Who runs Pulmotherapeutics Inc?

Pulmotherapeutics Inc's Form D of 2025-04-14 names Nagarjun Konduru Venkata as its officers, directors or promoters.

How much has Pulmotherapeutics Inc raised?

Its new offerings report $500K sold across 1 offering, as its own filings state.

Biotechnology · by week

Trailing twelve months. 766 filings in Biotechnology, totalled by week.

Want the whole picture on Pulmotherapeutics Inc?

What the filing shows about Pulmotherapeutics Inc

  • The filing reports $250K of the proceeds going to the company's own executives, directors or promoters.
  • 3 investors had already put money in when it filed.

Only in the Full Report: Who Runs It, And How To Reach Them · Warning Bells · Who Pays Them, And Who They Are Up Against.

Example from a real report (our sample on Target): “In March 2026, Target announced a planned incremental $1 billion operating investment” Source: Target Corporation (press release)

A Full Report on Pulmotherapeutics Inc: verified, sourced, every claim cited, ready in a few minutes. See pricing.

What the Full Report on Pulmotherapeutics Inc covers

  1. The Short Answer

  2. Which Company This Is

  3. What They Do, And How The Money Works

  4. Who Runs It, And How To Reach Them

  5. The Money: Funding, Valuation, Runway

  6. Who Pays Them, And Who They Are Up Against

  7. Warning Bells

  8. Sources

    1 cited source found

Plus the sections for what you are deciding, which you pick after ordering.

See a sample report

First screen of a real sample Full Report on EchoStar: the verdict, 17 sections, 63 cited sources, built 2026-10-21A real finished report, first screen. Opens in a new tab.

The full profile

Checking your access…

Is this you?

If you're behind Pulmotherapeutics Inc: the weeks after a raise are watched the same way — by other investors sizing you up, and by founders checking who just got funded. FoxPlug turns your commits, deploys, and releases into that story automatically. GetFoxChat puts a guide on your own site so the people this filing just sent you don't leave after one page.

Sourced from the filing index on sec.gov.

RSS

Tools for this story

Each opens in a new tab, filled in for Pulmotherapeutics Inc. With no account yet, you sign up free and land on the result.

Share this page

Is this your company?

Share your raise. This card is drawn from the company's own Form D filing, and sharing needs no account.

Pulmotherapeutics Inc: Raised $500K, Form D filed 2025-04-14
Share on LinkedIn Share on X Download image

Cite this page

Permanent URL: https://mentionfox.com/funding/pulmotherapeutics-inc-form-d-25000001
Last updated 2026-11-04
Primary record: SEC filing 1 · SEC filing 2
Pulmotherapeutics Inc raised $500K — SEC Form D filing, April 2025. MentionFox, 2026-11-04. https://mentionfox.com/funding/pulmotherapeutics-inc-form-d-25000001